International Workshop on Long Acting Anti-Infectives 2026

The 2nd International Workshop on Long Acting Anti-Infectives (LAAI) will take place in Philadelphia, USA and virtually from 20 to 21 May 2026.

LAAI 2026 is a dynamic forum advancing the development, implementation, and scale-up of long-acting and extended-release (LA/ER) anti-infective therapies.

This year’s program will examine the evolving landscape of HIV prevention and treatment, while broadening discussions to tuberculosis, malaria, hepatitis, and non-TB mycobacterial diseases. Sessions will explore innovative delivery platforms, behavioral and adherence strategies, drug resistance, and implementation challenges across diverse populations.

Through interactive talks, panel discussions, and debates, participants will engage with the latest scientific and programmatic insights shaping the next generation of long-acting therapies. By fostering collaboration among academia, industry, and global health partners, LAAI aims to drive innovation that improves access, adherence, and long-term outcomes across infectious diseases.

For full details about the workshop, click here.